Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also ...
Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...
A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the ...
Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...
Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...
People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...
The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...
A gene-editing therapy for sickle cell disease ... Crucially foetal haemoglobin is not affected by sickle cell disease, so ...
One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease ... to be licensed using gene-editing tool Crispr, which earned its inventors the ...